Skip to main content
. 2024 Feb 29;7(2):e240007. doi: 10.1001/jamanetworkopen.2024.0007

Table 1. Pooled Characteristics of Enrolled Individuals and CRC Incidence and Mortality From 4 Sigmoidoscopy Screening Trials.

Characteristic Total participants, No. (%) Usual care, participants, No. (%) Screening, participants, No. (%)
Nonattenders Attenders
Colonoscopya No colonoscopya
No. of individuals
Women 181 971 112 245 19 058 6138 44 530
Men 176 233 108 466 15 893 9796 42 078
Person-years, CRC incidence
Women 2 795 577 1 724 973 283 778 91 330 695 497
Men 2 590 547 1 589 544 218 599 142 282 640 122
CRC incidenceb
All 8508 (2.4) 5823 (2.6) 935 (2.7) 562 (3.5) 1188 (1.4)
Distal 4912 (1.4) 3526 (1.6) 577 (1.7) 384 (2.4) 425 (0.5)
Proximal 3523 (1.0) 2251 (1.0) 348 (1.0) 171 (1.1) 753 (0.9)
Women
All 3544 (1.9) 2368 (2.1) 411 (2.2) 180 (2.9) 585 (1.3)
Distal 1789 (1.0) 1260 (1.1) 225 (1.2) 120 (2.0) 184 (0.4)
Proximal 1729 (1.0) 1092 (1.0) 180 (0.9) 60 (1.0) 397 (0.9)
Men
All 4964 (2.8) 3455 (3.2) 524 (3.3) 382 (3.9) 603 (1.4)
Distal 3123 (1.8) 2266 (2.1) 352 (2.2) 264 (2.7) 241 (0.6)
Proximal 1794 (1.0) 1159 (1.1) 168 (1.1) 111 (1.1) 356 (0.8)
Person-years, CRC mortality
Women 2 947 166 1 803 074 303 858 101 242 738 991
Men 2 736 393 1 666 686 233 322 157 974 678 411
CRC mortalityb
All 2591 (0.7) 1784 (0.8) 328 (0.9) 113 (0.7) 366 (0.4)
Distal 1353 (0.4) 987 (0.4) 205 (0.6) 64 (0.4) 97 (0.1)
Proximal 1089 (0.3) 703 (0.3) 102 (0.3) 45 (0.3) 239 (0.3)
Women
All 1034 (0.6) 689 (0.6) 137 (0.7) 41 (0.7) 167 (0.4)
Distal 447 (0.2) 310 (0.3) 77 (0.4) 20 (0.3) 40 (0.1)
Proximal 523 (0.3) 338 (0.3) 52 (0.3) 21 (0.3) 112 (0.3)
Men
All 1557 (0.9) 1095 (1.0) 191 (1.2) 72 (0.7) 199 (0.5)
Distal 906 (0.5) 677 (0.6) 128 (0.8) 44 (0.4) 57 (0.1)
Proximal 566 (0.3) 365 (0.3) 50 (0.3) 24 (0.2) 127 (0.3)

Abbreviation: CRC, colorectal cancer.

a

Colonoscopy after positive finding at sigmoidoscopy screening.

b

Total number of CRC cases and CRC deaths is greater than the sum of cases by tumor location because of cancer cases with unspecified tumor location.